Sarah P. Hammond

Also affiliated with Massachusetts General Hospital, Dana-Farber Cancer Institute, Center for Cancer Research

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: “SARS-CoV-2 Virologic Rebound With Nirmatrelvir–Ritonavir Therapy”.

SARS-CoV-2 Virologic Rebound With Nirmatrelvir–Ritonavir Therapy

Annals of Internal Medicine(2023)10.7326/m23-1756

N/A

0DataRank · unranked

73 citations

Julie Boucau, Rockib Uddin, Caitlin Marino, May Y. Liew, Mamadou Barry +17 more

Respiratory infections predominate after day 100 following B-cell maturation antigen–directed CAR T-cell therapy

Blood Advances(2023)10.1182/bloodadvances.2023010524

N/A

0DataRank · unranked

39 citations

Megha Tandon, Joseph Hong, Omar Nadeem, Adam S. Sperling, Noopur Raje +5 more

SARS-CoV-2 Viral Clearance and Evolution Varies by Extent of Immunodeficiency

medRxiv(2023)10.1101/2023.07.31.23293441

N/A

0DataRank · unranked

11 citations

Manish C. Choudhary, James Regan, Julie Boucau, Anusha Nathan, Tessa Speidel +28 more

SARS-CoV-2 virologic rebound with nirmatrelvir-ritonavir therapy

medRxiv(2023)10.1101/2023.06.23.23288598

N/A

0DataRank · unranked

5 citations

Julie Boucau, Rockib Uddin, Caitlin Marino, May Y. Liew, Mamadou Barry +17 more

SARS-CoV-2 viral clearance and evolution varies by type and severity of immunodeficiency

Science Translational Medicine(2024)10.1126/scitranslmed.adk1599

N/A

0DataRank · unranked

98 citations

Manish C. Choudhary, James Regan, Julie Boucau, Anusha Nathan, Tessa Speidel +28 more

Modeling suggests SARS-CoV-2 rebound after nirmatrelvir-ritonavir treatment is driven by target cell preservation coupled with incomplete viral clearance

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.09.13.613000

N/A

0DataRank · unranked

2 citations

Ruy M. Ribeiro, Gregory E. Edelstein, Julie Boucau, Rockib Uddin, Caitlin Marino +20 more

Modeling suggests SARS-CoV-2 rebound after nirmatrelvir-ritonavir treatment is driven by target cell preservation coupled with incomplete viral clearance

Journal of Virology(2025)10.1128/jvi.01623-24

N/A

0DataRank · unranked

18 citations

Ruy M. Ribeiro, Gregory E. Edelstein, Julie Boucau, Rockib Uddin, Caitlin Marino +20 more